Komori
Share Issuance and Disposal4576D.Western Therapeutics Institute, Inc.Pharmaceuticals

Supplementary Materials on Fundraising

Provides supplementary details on the purpose of the financing, use of proceeds, financing terms and development plans for the 14th Stock Acquisition Rights and 2nd Unsecured Bonds. It does not state the figures before and after correction or identify the original disclosure subject to correction.

Worth reading
0Immaterial
Scored from 2 of 3 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
3086
Million yen (approximate net proceeds from the 14th Stock Acquisition Rights)
Wording
Conditional
How definitive the wording is.

What was corrected and how

A subsequent correction by the company to the contents of an already published filing.

Original disclosure
The number of days elapsed cannot be calculated because the original disclosure date is unknown.
This correction2026-09-14
What was corrected and how
ItemDetails
Items this document does not state (6)
Disclosure subject to correctionOriginal disclosure dateLocation of correctionDetails of correctionReason for correctionImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The materials appear to have been prepared as supplementary information for explaining the financing overview, the reasons for selecting the financing method and the use of proceeds to investors, although they do not expressly state the reason for their preparation.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Supplementary Materials on Fundraising | D.Western Therapeutics Institute, Inc. (4576) timely disclosure | Komori